Application no. and date | 11778000.7 (espacenet) (Federated) (European Patent Register), 20110428 | Patent/reg. no. and date | DK/EP 2563385, 20170802 | Publication date | 20130306 | Priority no. and date | US 329078 P, 20100428 | EP pub. no. and date |
EP 2563385 20130306 | Effective date | | Applicant/owner | Oncoimmune Inc., 12111 Parklawn Drive, Suite 107 Rockville Maryland 20852-1707, US | Applicant ref. no. | P81204549DK00E | Inventor | ZHENG, Pan, 4970 Red Fox Run
Ann Arbor, MI 48105, US, ZHENG, Xincheng, 2411 Meadowridge Court
Ann Arbor, MI 48103, US, WU, Wei, 2106 Pauline Boulevard Apt. 104
Ann Arbor, MI 48103, US, LIU, Yang, 4970 Red Fox Run
Ann Arbor, MI 48105, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61P 19/02 (2006.01) , C07K 14/705 (2006.01) | Title | FREMGANGSMÅDER TIL ANVENDELSE AF OPLØSELIG CD24 TIL BEHANDLING AF REUMATOID ARTRITIS | Int. application no. | US2011034282 | Int. publication no. | WO2011139820 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|